PPARG and metabolic dysfunction-associated steatotic liver disease: Zhou et al. [47] replicated this finding in an independent cohort, demonstrating that PPARG c.C161T and other polymorphisms are associated with the levels of tumor necrosis factor (TNF)-alpha, leptin, and adiponectin in NAFLD.